Tharimmune to present at the microcap conference 2025

Bridgewater, nj / access newswire / january 27, 2025 / tharimmune, inc. (nasdaq:thar) ("tharimmune" or the "company"), a clinical-stage biotechnology company committed to pioneering therapies in immunology and inflammation, today announced its participation in the microcap conference 2025 being held january 28-30, 2025, in atlantic city, n.j. management will deliver a corporate presentation and engage in one-on-one meetings with institutional and individual investors to discuss the company's recent developments, growth strategy, and investment opportunities.
THAR Ratings Summary
THAR Quant Ranking